{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"41fdbd2dc2bc","filters":{"venue":"Drug Discovery Today Therapeutic Strategies"}},"results":[{"id":"W2066470480","doi":"10.1016/j.ddstr.2008.05.005","title":"Cardiovascular consequences of obesity","year":2008,"lang":"en","type":"article","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Obesity; Medicine; Diabetes mellitus; Disease; Body mass index; Metabolic syndrome; Obstructive sleep apnea; Sleep apnea; Type 2 diabetes; Developed country; Internal medicine; Environmental health; Endocrinology; Population","authors":[{"name":"Paul Poirier","is_ca":true},{"name":"Robert H. Eckel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02426041976850105,"gpt":0.248128240180448,"spread":0.2238678204119469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004182368,0.0003462448,0.0003828824,0.0004251204,0.0002762371,0.0009557574,0.0001822592,0.00056821,0.001956948],"category_scores_gemma":[0.0007072301,0.0001282141,0.0003465561,0.0003185928,0.0003510734,0.0002272571,0.0003321426,0.001528656,0.0002157733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002749326,"about_ca_system_score_gemma":0.0004567822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001031417,"about_ca_topic_score_gemma":0.001798682,"domain_scores_codex":[0.999743,0.0001078,0.00001270587,0.00002544264,0.00006746006,0.00004354934],"domain_scores_gemma":[0.9997267,0.00007419608,0.00006530967,0.00002899304,0.00003807271,0.00006677351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007186085,0.001445731,0.1651404,0.001575839,0.001271265,0.006906237,0.0003701324,0.001193112,0.07100844,0.04833296,0.02083526,0.6747346],"study_design_scores_gemma":[0.0003373561,0.001873342,0.8616905,0.0006306616,0.001215968,0.008501505,0.0005616419,0.001082349,0.006589982,0.04666303,0.07078647,0.00006718824],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.5522224,0.3238099,0.003772323,0.03595958,0.002899999,0.00005466347,0.001030839,0.0001129631,0.08013728],"genre_scores_gemma":[0.891614,0.0901293,0.001530877,0.004112423,0.004380918,0.00003245008,0.0004449765,0.00001293617,0.007742162],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.001956948,"threshold_uncertainty_score":0.006546617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979457312","doi":"10.1016/j.ddstr.2013.11.001","title":"Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure","year":2012,"lang":"en","type":"review","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Heart and Stroke Foundation of Canada","keywords":"Angiotensin-converting enzyme 2; Heart failure; Angiotensin II; Angiotensin II receptor type 1; Pressure overload; Internal medicine; Receptor; Endocrinology; Renin–angiotensin system; Ventricular remodeling; Medicine; Muscle hypertrophy; Angiotensin-converting enzyme; Myocardial infarction; Angiotensin 1; Fibrosis; Blood pressure; Pharmacology; Cardiac hypertrophy; Disease","authors":[{"name":"Vaibhav B. Patel","is_ca":true},{"name":"Brendan Putko","is_ca":true},{"name":"Zuocheng Wang","is_ca":true},{"name":"Jiuchang Zhong","is_ca":false},{"name":"Gavin Y. Oudit","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05245593690220392,"gpt":0.3157799530829468,"spread":0.2633240161807429,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058302,0.0009159789,0.001744553,0.001342254,0.0001551933,0.0007167954,0.0006146102,0.0007850013,0.002219474],"category_scores_gemma":[0.0006468759,0.0002517454,0.0005302105,0.001069149,0.0003272534,0.0009293137,0.0003993625,0.001501288,0.0009017289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002872621,"about_ca_system_score_gemma":0.000598921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004346467,"about_ca_topic_score_gemma":0.001191884,"domain_scores_codex":[0.999878,0.00002080861,0.0000223759,0.00002258844,0.00004396218,0.00001212478],"domain_scores_gemma":[0.9997372,0.0001639224,0.00003944325,0.000005877293,0.00003599441,0.00001752528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000381302,0.0002081477,0.0002447329,0.02257132,0.0002990757,0.0003491207,0.00002975285,0.0003242246,0.004523022,0.001647845,0.01600888,0.9534125],"study_design_scores_gemma":[0.0005632158,0.0009458206,0.002942609,0.006999483,0.001942987,0.003215692,0.0001083353,0.0005207747,0.004742234,0.003831304,0.974114,0.0000735663],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002196751,0.9989032,0.0001487793,0.0001642043,0.0001216539,0.000004483095,0.00001241536,0.000005685683,0.0004199152],"genre_scores_gemma":[0.001318746,0.9976647,0.0002448841,0.0002299381,0.0001866693,0.000007018412,0.00002026132,0.000001068113,0.0003268182],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002219474,"threshold_uncertainty_score":0.007424891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055678521","doi":"10.1016/j.ddstr.2008.10.001","title":"Cognitive enhancing drugs for schizophrenia","year":2008,"lang":"en","type":"article","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Schizophrenia (object-oriented programming); Cognition; Psychology; Dopamine; Dopamine hypothesis of schizophrenia; Neuroscience; Medicine; Psychiatry; Dopamine receptor D2","authors":[{"name":"Thomas J. Raedler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01668047938715617,"gpt":0.2651454815594377,"spread":0.2484650021722816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001937201,0.0005361282,0.0003216542,0.0005277294,0.0003214062,0.0003710805,0.0003039603,0.0003836555,0.005177041],"category_scores_gemma":[0.0001679273,0.00006622831,0.0002574552,0.0001997844,0.0004315673,0.0002509455,0.0003788832,0.001062797,0.00105377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005480358,"about_ca_system_score_gemma":0.0008170927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001658281,"about_ca_topic_score_gemma":0.005229452,"domain_scores_codex":[0.9999568,0.00000947238,0.000003586652,0.000004727839,0.00001413524,0.00001115087],"domain_scores_gemma":[0.9999446,0.00001106002,0.00001458874,0.000003740974,0.000009418504,0.00001671368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001754022,0.0005166568,0.0008291683,0.001357474,0.00008283649,0.001398725,0.0001432883,0.0003865026,0.05299278,0.04480907,0.03438335,0.8613461],"study_design_scores_gemma":[0.001722762,0.003227045,0.01119407,0.0008625679,0.0003991485,0.005546051,0.0002819263,0.0008621791,0.04676041,0.0605984,0.8684403,0.0001051489],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1373675,0.7046368,0.00796451,0.02914939,0.003046531,0.0001876658,0.001194211,0.0007477358,0.1157058],"genre_scores_gemma":[0.4398916,0.4966671,0.006667521,0.007907497,0.0009862705,0.000132644,0.0005051549,0.00005132404,0.04719092],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005177041,"threshold_uncertainty_score":0.01731896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}